8-hydroxy-2-(di-n-propylamino)tetralin and amperozide

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with amperozide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meltzer, HY; Willins, DL1
Hull, EE; Koob, GF; McArthur, RA; Post, C; Roberts, AJ1
Ichikawa, J; Meltzer, HY1

Other Studies

3 other study(ies) available for 8-hydroxy-2-(di-n-propylamino)tetralin and amperozide

ArticleYear
Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens.
    Brain research, 1998, Jan-19, Volume: 781, Issue:1-2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Male; Microdialysis; Morphine; Narcotic Antagonists; Nucleus Accumbens; Piperazines; Pyrazines; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Serotonin Receptor Agonists

1998
Effects of amperozide, 8-OH-DPAT, and FG 5974 on operant responding for ethanol.
    Psychopharmacology, 1998, Volume: 137, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Conditioning, Operant; Ethanol; Male; Nicotinic Acids; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists

1998
The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Brain research, 2000, Mar-10, Volume: 858, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Clozapine; Corpus Striatum; Dopamine; Fluorobenzenes; Haloperidol; Male; Microdialysis; Nucleus Accumbens; Piperazines; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Risperidone; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium

2000